Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2017	Jun. 30, 2017
Current assets:
Cash and cash equivalents		$ 2,363.6	$ 2,780.4
Accounts receivable, net of allowance for doubtful accounts of $54.0 and $49.6, respectively		1,788.7	1,703.6
Other current assets		1,164.1	883.2
Total current assets before funds held for clients		5,316.4	5,367.2
Funds held for clients		25,686.2	27,291.5
Total current assets		31,002.6	32,658.7
Long-term receivables, net of allowance for doubtful accounts of $0.8 and $0.8, respectively		27.3	28.0
Property, plant and equipment, net		800.4	779.9
Other assets		1,386.2	1,352.2
Goodwill		1,757.3	1,741.0
Intangible assets, net		687.3	620.2
Total assets		35,661.1	37,180.0
Current liabilities:
Accounts payable		112.6	149.7
Accrued expenses and other current liabilities		1,440.4	1,381.9
Accrued payroll and payroll-related expenses		441.1	562.5
Dividends payable		249.0	250.5
Short-term deferred revenues		230.5	232.9
Obligations under reverse repurchase agreements	[1]	129.4	0.0
Income taxes payable		87.0	49.0
Total current liabilities before client funds obligations		2,690.0	2,626.5
Client funds obligations		25,596.6	27,189.4
Total current liabilities		28,286.6	29,815.9
Long-term debt		2,002.1	2,002.4
Other liabilities		835.5	830.2
Deferred income taxes		196.0	163.1
Long-term deferred revenues		387.5	391.4
Total liabilities		31,707.7	33,203.0
Commitments and contingencies (Note 12)
Stockholders' equity:
Preferred stock, $1.00 par value: Authorized, 0.3 shares; issued, none		0.0	0.0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at September 30, 2017 and June 30, 2017 outstanding, 444.0 and 445.0 shares at September 30, 2017 and June 30, 2017, respectively		63.9	63.9
Capital in excess of par value		869.8	867.8
Retained earnings		14,872.4	14,728.2
Treasury stock - at cost: 194.7 and 193.7 shares at September 30, 2017 and June 30, 2017, respectively		(11,508.1)	(11,303.7)
Accumulated other comprehensive loss		(344.6)	(379.2)
Total stockholders’ equity		3,953.4	3,977.0
Total liabilities and stockholders’ equity		35,661.1	37,180.0
Short-term marketable securities under reverse repurchase agreements		110.0	0.0
Long-term marketable securities under reverse repurchase agreements		19.3	0.0
Cash and cash equivalents under reverse repurchase agreements		$ 0.1	$ 0.0

[1] (A) As of September 30, 2017, $110.0 million of short-term marketable securities, $19.3 million of long-term marketable securities and $0.1 million of cash and cash equivalents have been pledged as collateral under the Company's reverse repurchase agreements (see Note 8).